CorEvitas

Corrona Provides Real-World Evidence Through Joint Registry Data and Analytical Services, Helping Biopharmaceutical Companies Demonstrate the Value and Differentiation of Their Products to Clinicians, Patients, Payers, and Regulatory Authorities.The depth and comprehensiveness of Corrona’s data in clinical measurements and patient-reported outcomes are unparalleled. Corrona also conducts proactive safety monitoring to support regulatory commitments for 14 new drug approvals, including formal post-authorization safety studies. The company's mission is to advance patient care and improve treatments through real-world data analysis.